Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
- 13 June 2017
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 67 (5), 933-939
- https://doi.org/10.1016/j.jhep.2017.05.028
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infectionThe Esophagus, 2013
- A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitisScientific Reports, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infectionHepatology, 2010
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis CNature Genetics, 2009
- Potential Relevance of Cytoplasmic Viral Sensors and Related Regulators Involving Innate Immunity in Antiviral ResponseGastroenterology, 2008
- FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestHepatology, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology, 2003
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994